<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33154354</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Nonmuscle myosin IIB regulates Parkin-mediated mitophagy associated with amyotrophic lateral sclerosis-linked TDP-43.</ArticleTitle><Pagination><StartPage>952</StartPage><MedlinePgn>952</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">952</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-020-03165-7</ELocationID><Abstract><AbstractText>C-terminal fragments of Tar DNA-binding protein 43 (TDP-43) have been identified as the major pathological protein in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, how they affect cellular toxicity and neurodegeneration, including the modulation process remains unknown. This study revealed that the C-terminal fragment of TDP-43 (TDP-25) was localized primarily to mitochondria and caused abnormal mitochondrial morphology, inducing Parkin-mediated mitophagy. Also, we discovered that the knockdown of selective autophagy receptors, such as TAX1BP, Optineurin, or NDP52 caused TDP-25 accumulation, indicating that TDP-25 was degraded by mitophagy. Interestingly, myosin IIB, a nonmuscle type of myosin and actin-based motor protein, is mostly colocalized to TDP-25 associated with abnormal mitochondria. In addition, myosin IIB inhibition by siRNA or blebbistatin induced mitochondrial accumulation of insoluble TDP-25 and Tom20, and reduced neuronal cell viability. Our results suggest a novel role of myosin IIB in mitochondrial degradation of toxic TDP-25. Therefore, we proposed that regulating myosin IIB activity might be a potential therapeutic target for neurodegenerative diseases associated with TDP-43 pathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jun</LastName><ForeName>Mi-Hee</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jae-Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Pureum</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soo-Kyung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang-Hoon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Brain Research Core Facilities Center, Korea Brain Research Institute, Daegu, 41062, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Ha-Eun</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>You-Kyung</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Haneul</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang-Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Ecological Science, College of Ecology and Environment, Kyungpook National University, Sangju-si, 37224, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeongyeon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain Research Core Facilities Center, Korea Brain Research Institute, Daegu, 41062, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Deok-Jin</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Ecological Science, College of Ecology and Environment, Kyungpook National University, Sangju-si, 37224, Republic of Korea. jangdj@knu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-6757-8371</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology and Biological Sciences, Hannam University, Daejeon, 34054, Republic of Korea. leeja@hnu.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C574535">TDP-25 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D024501">Nonmuscle Myosin Type IIB</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="Y">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024501" MajorTopicYN="N">Nonmuscle Myosin Type IIB</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>5</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33154354</ArticleId><ArticleId IdType="pmc">PMC7645685</ArticleId><ArticleId IdType="doi">10.1038/s41419-020-03165-7</ArticleId><ArticleId IdType="pii">10.1038/s41419-020-03165-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK. The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front. Neurosci. 2019;13:335. doi: 10.3389/fnins.2019.00335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010;19:R46&#x2013;R64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Yan T, Perry G, Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell. Neurosci. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, et al. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryson K, et al. Protein structure prediction servers at University College London. Nucleic Acids Res. 2005;33:W36&#x2013;W38. doi: 10.1093/nar/gki410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki410</ArticleId><ArticleId IdType="pmc">PMC1160171</ArticleId><ArticleId IdType="pubmed">15980489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella RA-O, Fani GA-O, Bigi AA-O, Chiti F, Cecchi CA-O. Partial failure of proteostasis systems counteracting TDP-43 aggregates in neurodegenerative diseases. Int. J. Mol. Sci. 2019;20:3685. doi: 10.3390/ijms20153685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153685</ArticleId><ArticleId IdType="pmc">PMC6695586</ArticleId><ArticleId IdType="pubmed">31357627</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SA, et al. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci. Lett. 2018;678:8&#x2013;15. doi: 10.1016/j.neulet.2018.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.053</ArticleId><ArticleId IdType="pmc">PMC5975202</ArticleId><ArticleId IdType="pubmed">29715546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K, et al. Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line. Neurosci. Lett. 2012;530:144&#x2013;149. doi: 10.1016/j.neulet.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.10.003</ArticleId><ArticleId IdType="pubmed">23063673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruppa AJ, et al. Myosin VI-dependent actin cages encapsulate Parkin-positive damaged mitochondria. Dev. Cell. 2018;44:484&#x2013;499. doi: 10.1016/j.devcel.2018.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2018.01.007</ArticleId><ArticleId IdType="pmc">PMC5932465</ArticleId><ArticleId IdType="pubmed">29398621</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobova F, Gauvin TJ, Higgs HN. A role for myosin II in mammalian mitochondrial fission. Curr. Biol. 2014;24:409&#x2013;414. doi: 10.1016/j.cub.2013.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2013.12.032</ArticleId><ArticleId IdType="pmc">PMC3958938</ArticleId><ArticleId IdType="pubmed">24485837</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeding SA-O, et al. Identification of Miro1 and Miro2 as mitochondrial receptors for myosin XIX. J. Cell Sci. 2018;131:jcs219469. doi: 10.1242/jcs.219469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.219469</ArticleId><ArticleId IdType="pubmed">30111583</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Svitkina TM. Ultrastructure and dynamics of the actin-myosin II cytoskeleton during mitochondrial fission. Nat. Cell Biol. 2019;21:603&#x2013;613. doi: 10.1038/s41556-019-0313-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0313-6</ArticleId><ArticleId IdType="pmc">PMC6499663</ArticleId><ArticleId IdType="pubmed">30988424</ArticleId></ArticleIdList></Reference><Reference><Citation>Roossien DH, Lamoureux P, Miller KE. Cytoplasmic dynein pushes the cytoskeletal meshwork forward during axonal elongation. J. Cell Sci. 2014;127:3593&#x2013;3602. doi: 10.1242/jcs.152611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.152611</ArticleId><ArticleId IdType="pubmed">24951117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kneussel M, Wagner W. Myosin motors at neuronal synapses: drivers of membrane transport and actin dynamics. Nat. Rev. Neurosci. 2013;14:233&#x2013;247. doi: 10.1038/nrn3445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3445</ArticleId><ArticleId IdType="pubmed">23481482</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Neuropathy due to impaired axonal transport of non-fragmented mitochondria in MYH14 mutation carriers. EBioMedicine. 2019;49:24. doi: 10.1016/j.ebiom.2019.09.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.09.056</ArticleId><ArticleId IdType="pmc">PMC6945270</ArticleId><ArticleId IdType="pubmed">31653586</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-S&#xe1;nchez R, et al. Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression. Neurobiol. Dis. 2014;62:426&#x2013;440. doi: 10.1016/j.nbd.2013.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.10.021</ArticleId><ArticleId IdType="pmc">PMC3898697</ArticleId><ArticleId IdType="pubmed">24184327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentmann E, Haass C, Dormann D. Stress granules in neurodegeneration&#x2013;lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J. 2013;280:4348&#x2013;4370. doi: 10.1111/febs.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12287</ArticleId><ArticleId IdType="pubmed">23587065</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru S, et al. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: evidence for loss of TDP-43 nuclear function. Hum. Mol. Genet. 2016;25:4473&#x2013;4483.</Citation><ArticleIdList><ArticleId IdType="pubmed">28172957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, et al. Mitophagy and its contribution to metabolic and aging associated disorders. Antioxid. Redox Signal. 2020;32:906&#x2013;927. doi: 10.1089/ars.2019.8013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2019.8013</ArticleId><ArticleId IdType="pubmed">31969001</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiyama A, Okamoto K. PINK1/Parkin-mediated mitophagy in mammalian cells. Curr. Opin. Cell Biol. 2015;33:95&#x2013;101. doi: 10.1016/j.ceb.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2015.01.002</ArticleId><ArticleId IdType="pubmed">25697963</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, Wilce JA. TDP-43 and FUS-structural insights into RNA recognition and self-association. Curr. Opin. Struct. Biol. 2019;59:134&#x2013;142. doi: 10.1016/j.sbi.2019.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.07.012</ArticleId><ArticleId IdType="pubmed">31479821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Filadi R, Pendin D, Pizzo P. Mitofusin 2: from functions to disease. Cell Death Dis. 2018;9:330. doi: 10.1038/s41419-017-0023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0023-6</ArticleId><ArticleId IdType="pmc">PMC5832425</ArticleId><ArticleId IdType="pubmed">29491355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodavati M, Wang H, Hegde ML. Altered mitochondrial dynamics in motor neuron disease: an emerging perspective. Cells. 2020;9:1065. doi: 10.3390/cells9041065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9041065</ArticleId><ArticleId IdType="pmc">PMC7226538</ArticleId><ArticleId IdType="pubmed">32344665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Vigie P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol. 2018;28:R170&#x2013;R185. doi: 10.1016/j.cub.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.01.004</ArticleId><ArticleId IdType="pmc">PMC7255410</ArticleId><ArticleId IdType="pubmed">29462587</ArticleId></ArticleIdList></Reference><Reference><Citation>Fili N, Toseland CP. Unconventional myosins: how regulation meets function. Int. J. Mol. Sci. 2019;21:67. doi: 10.3390/ijms21010067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21010067</ArticleId><ArticleId IdType="pmc">PMC6981383</ArticleId><ArticleId IdType="pubmed">31861842</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>